Alpha Cognition Inc
ACOG
Rangering i aksjer
#20080
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Aksjekurs
$8.66
Markedsverdi
$134.50M
Endring (1 dag)
1.88%
Endring (1 år)
72.17%
Land
US
Handel Alpha Cognition Inc (ACOG)
Kategori
Healthcare
Antall utestående aksjer for Alpha Cognition Inc (ACOG)
Antall utestående aksjer per June 2026: 21.77M
Ifølge Alpha Cognition Inc sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 21.77M. Ved slutten av December 2022 hadde selskapet 67.97M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Alpha Cognition Inc (ACOG) fra 2018 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 21.77M | -76.92% |
| 2023 | 94.36M | 38.81% |
| 2022 | 67.97M | 27.45% |
| 2021 | 53.33M | 786.67% |
| 2020 | 6.02M | -80.88% |
| 2019 | 31.46M | 2,539.28% |
| 2018 | 1.19M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 253.90M | 1,066.06% |
US
|
|
| 396.00M | 1,718.67% |
US
|
|
| 478.91M | 2,099.46% |
AU
|
|
| - | - |
CH
|
|
| 62.19M | 185.59% |
NL
|
